
Inspiration Healthcare Group plc (IHC.L) is a global provider of advanced medical technology, catering to critical care, operating theatre, and home healthcare applications worldwide. The company offers a comprehensive range of products, with a strong focus on neonatal intensive care. This includes air/oxygen blenders; the Tecotherm Neo, a sophisticated servo-controlled device that precisely manages infant body temperature through continuous cooling and warming, making minute adjustments every two seconds to ensure stability; LifeStart, a bedside unit for neonatal resuscitation; and Inspire rPAP, a non-invasive, two-piece system crucial for the initial stabilization and resuscitation of infants. Beyond neonatal care, Inspiration Healthcare also supplies adult intensive care solutions, such as AlphaCore5, a patient warming system designed to prevent inadvertent hypothermia. For neonates, they provide CosyTherm2, another dedicated patient warming system for precise temperature management. Their offerings also encompass various respiratory disposables and thermoregulating products specifically for babies. In addition to its proprietary innovations, the company distributes third-party medical products, including infusion therapy items vital for parenteral feeding and chemotherapy. Inspiration Healthcare Group further enhances its services by offering technology support and supplying spare parts. Established in 1998, Inspiration Healthcare Group plc maintains its headquarters in Crawley, United Kingdom.
Inspiration Healthcare Group plc trades as IHC.L on LSE. The company is classified in Healthcare / Medical - Devices and reports in GBP.
The current profile places the business in Medical - Devices. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Latest available fiscal data shows £38.25M of revenue and -£14.97M of net income.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Inspiration Healthcare Group plc can be compared against peers such as Abingdon Health Plc, Aptamer Group plc, Cambridge Cognition Holdings Plc, Fusion Antibodies plc, GENinCode plc, MyHealthChecked PLC.
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of £23.76M, beta of 0.87, and return on equity of -90.0%.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
IHC.L currently shows total debt of £14.97M and beta of 0.87. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.inspiration-healthcare.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.